Codexis (CDXS) Expected to Announce Quarterly Earnings on Thursday

Codexis (NASDAQ:CDXS) is expected to be announcing its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $27.41 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Codexis Price Performance

CDXS stock opened at $4.02 on Wednesday. The stock has a 50-day moving average price of $4.65 and a two-hundred day moving average price of $3.95. Codexis has a 1 year low of $2.56 and a 1 year high of $6.08. The stock has a market cap of $327.22 million, a PE ratio of -4.62 and a beta of 2.12. The company has a current ratio of 3.21, a quick ratio of 3.15 and a debt-to-equity ratio of 0.39.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CDXS. Benchmark reaffirmed a “hold” rating on shares of Codexis in a research report on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $11.00 price target on shares of Codexis in a research report on Friday, November 22nd.

Codexis Company Profile

Codexis, Inc discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.